Last reviewed · How we verify
Hyperuricemia
Approved treatments
- Urece · Fuji Yakuhin
- Zurampic · Ironwood Pharms Inc
- Uriadec · Senwa Kegaku Kenkyushp
- Adenuric · Pharmtechnology LLC
- Uloric · Takeda
Uloric works by blocking the enzyme xanthine dehydrogenase/oxidase, which is involved in the production of uric acid. - Aloprim · Casper Pharma Llc
Aloprim works by inhibiting the enzyme xanthine oxidase, which is responsible for producing uric acid in the body. - Col-Probenecid · Pfizer Inc.
ORLYNVAH combines sulopenem etzadroxil, a penem antibacterial, with probenecid to increase sulopenem's plasma concentration by inhibiting its renal clearance. - Azubromaron
- Benzbromaron · Amsterdam UMC, location VUmc
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hyperuricemia patent landscape — cliff calendar, originator estates, attackable patents
- Hyperuricemia treatment landscape brief
- Hyperuricemia treatment updates RSS
Frequently asked questions about Hyperuricemia
What drugs treat Hyperuricemia?
Tracked treatments include Urece, Zurampic, Uriadec, Adenuric, Uloric, Aloprim, Col-Probenecid, Azubromaron.
What is the treatment for Hyperuricemia?
Standard treatment for Hyperuricemia includes Urece, Zurampic, Uriadec, Adenuric, Uloric. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hyperuricemia patent cliff · Hyperuricemia CI report
- Treatment: Urece · Fuji Yakuhin
- Treatment: Zurampic · Ironwood Pharms Inc
- Treatment: Uriadec · Senwa Kegaku Kenkyushp
- Treatment: Adenuric · Pharmtechnology LLC
- Treatment: Uloric · Takeda
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing